Angina Pectoris: Clinical Trials

3 trials for Angina Pectoris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Completed 1, Terminated 1, Unknown 1

Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions
AUX-001 40mg once-daily - Chronic Stable Angina
Early Phase 1UnknownAuxilius Pharma sp.z.o.o.162023-11-272024-02-12
Acupoint Application in Patients With Stable Angina Pectoris (AASAP)
Herbal plaster ( styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech), acupoint, Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn. - Stable Angina Pectoris
Early Phase 1CompletedChengdu University of Traditional Chinese Medicine2002012-10-012020-02-17
Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)
Regadenoson, Dobutamine - Coronary Artery Disease, Asthma
Early Phase 1TerminatedWake Forest University Health Sciences142009-01-012018-09-26

Narrower conditions

Angina, Stable (2)  ·  Asthma (1)  ·  Coronary Artery Disease (1)  ·  Coronary Disease (1)  ·  Fasting (1)  ·  Lecithin Cholesterol Acyltransferase Deficiency (1)  ·  Myocardial Ischemia (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Chest Pain (3)  ·  Heart Diseases (3)  ·  Neurologic Manifestations (3)  ·  Pain (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  Myocardial Ischemia (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Behavior (1)  ·  Bronchial Diseases (1)  ·  Chronic Disease (1)

Interventions

Acupuncture Points (1)  ·  Aspirin (1)  ·  Dobutamine (1)  ·  Frankincense (1)  ·  Leeching (1)  ·  isoborneol (1)  ·  regadenoson (1)  ·  storax (1)

Sponsors

Auxilius Pharma sp.z.o.o. (1)  ·  Chengdu University of Traditional Chinese Medicine (1)  ·  Wake Forest University Health Sciences (1)

Countries

China (1)  ·  Portugal (1)  ·  United States (1)

Top investigators

Fanrong Liang (1)  ·  Marlene Fonseca, MD (1)  ·  William G Hundley, M.D., F.A.C.C., F.A.H.A (1)

Results publications

PMID 25250055, PMID 34387828

NIH funding

2023 (1)